US life sciences sector will take on more tech

The US life sciences sector risks research funding shortfalls, but new avenues are opening in medical technology

You must be signed in to read this analysis

Sign in Sign up to our newsletter

In this article

  • Basic research risks
  • Digital ecosystems

What is this?

This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.